Professor Scott Manalis and Keith Ligon of the Dana-Farber Cancer Institute have published a paper in Cell Reports, out today.
MIT Center for M-CELS Member Scott Manalis developed a new way to determine whether individual patients will respond to a specific cancer drug or not